Philips Ventures, the strategic venture capital arm of Philips, focuses on early- and growth-stage investments in health technology companies that align with Philips' businesses and address unmet healthcare needs. Their strategy often involves investing in companies with a potential for future acquisition by Philips.
100% of their portfolio is in Healthcare. They made 1 investments in the last 12 months. Their most common stage is series-a (40% of deals). Average disclosed round size is $44.5M (across 10 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 PreciseDx | Unknown | $11M | Jun 2025 |
 IOMED | Series A | $10.8M | Sep 2023 |
| MMoving Analytics | Series A | $20M | Jul 2022 |
 CVAid Medical | Series A | $4M | Feb 2022 |
 Babyscripts | Series B | $12M | Sep 2021 |
| DDoctor Anywhere | Series C | $65.7M | Aug 2021 |
| DDiA Imaging Analysis | Series B | $14M | Aug 2021 |
 Xealth | Series A | $11M | Mar 2019 |
| Babyscripts | Seed | $6M | Jan 2019 |
| AAmerican Well | Growth | $291M | Jun 2018 |
Top Co-Investors
XTX Ventures2 shared
EDBI1 shared
Square Peg Capital1 shared
Pavilion Capital1 shared
Eventide Asset Management1 shared
Merck Global Health Innovation Fund1 shared
Labcorp1 shared
McKesson Ventures1 shared
Novartis Venture Fund1 shared
Threshold Ventures1 shared
Providence Ventures1 shared
Alchimia Investments1 shared
Icon Ventures1 shared
CE Ventures1 shared
Connecticut Innovations1 shared
Mindset Venture1 shared
Fondo Bolsa Social1 shared
Redseed1 shared
Adara Ventures1 shared
MemorialCare Innovation Fund1 shared
Last updated: 16 April 2026